A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.

MLA

Neumayer, Gernot, et al. “A Scalable and CGMP-Compatible Autologous Organotypic Cell Therapy for Dystrophic Epidermolysis Bullosa.” Nature Communications, vol. 15, no. 1, July 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1038/s41467-024-49400-z.

APA

Neumayer, G., Torkelson, J. L., Li, S., McCarthy, K., Zhen, H. H., Vangipuram, M., Mader, M. M., Gebeyehu, G., Jaouni, T. M., Jacków-Malinowska, J., Rami, A., Hansen, C., Guo, Z., Gaddam, S., Tate, K. M., Pappalardo, A., Li, L., Chow, G. M., Roy, K. R., & Nguyen, T. M. (2024). A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa. Nature Communications, 15(1), 1–18. https://doi.org/10.1038/s41467-024-49400-z

Chicago

Neumayer, Gernot, Jessica L. Torkelson, Shengdi Li, Kelly McCarthy, Hanson H. Zhen, Madhuri Vangipuram, Marius M. Mader, et al. 2024. “A Scalable and CGMP-Compatible Autologous Organotypic Cell Therapy for Dystrophic Epidermolysis Bullosa.” Nature Communications 15 (1): 1–18. doi:10.1038/s41467-024-49400-z.